UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | J | K | L | M | N | O | P | Q | R | S | T | V | W | Y
Number of items: 214.

A

Adams, MJ; Cardigan, RA; Marchant, WA; Grocott, MPW; Mythen, MG; Mutch, M; Purdy, G; ... Machin, SJ; + view all (2002) Tissue factor pathway inhibitor antigen and activity in 96 patients receiving heparin for cardiopulmonary bypass. J CARDIOTHOR VASC AN , 16 (1) 59 - 63. 10.1053/jcan.2002.29677.

Ancliff, PJ; Gale, RE; Somerville, TC; Kwaja, A; Liesner, R; Hann, IM; Linch, DC; (2002) Complete inhibition of neutrophil elastase fails to correct the in vitro phenotype of severe congenital neutropenia. In: BLOOD. (pp. 243A - 243A). AMER SOC HEMATOLOGY

Ancliff, PJ; Gale, RE; Watts, MJ; Liesner, R; Hann, IM; Strobel, S; Linch, DC; (2002) Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia. Blood , 100 (2) pp. 707-709. 10.1182/blood-2002-01-0060. Green open access
file

Ancliff, PJ; Gale, RE; Watts, MJ; Liesner, R; Hann, IM; Strobel, S; Linch, DC; (2002) Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia. BLOOD , 100 (2) 707 - 709.

Ardeshna, KM; Pizzey, AR; Walker, SJ; Devereux, S; Khwaja, A; (2002) The upregulation of CC chemokine receptor 7 and the increased migration of maturing dendritic cells to macrophage inflammatory protein 3 beta and secondary lymphoid chemokine is mediated by the p38 stress-activated protein kinase pathway. BRIT J HAEMATOL , 119 (3) 826 - 829.

Asher, D; Atterbury, C; Chapman, C; Cohen, H; Jones, H; Love, E; (2002) The 2000/2001 annual SHOT report (on behalf of the serious hazards of transfusion steering group).

Avivi, I; Bacon, CM; Obermann, EC; Quian, WD; Smith, P; Linch, DC; Dogan, A; (2002) Histological and clinical prognostic factors in follicular lymphoma: Proposal for a prognostic model. In: BLOOD. (pp. 37A - 37A). AMER SOC HEMATOLOGY

Avivi, I; Kyriakou, C; Kottaridis, PD; Chakrabarti, S; Goldstone, AH; Mackinnon, S; (2002) Neurological complications post low intensity bone marrow transplantation. In: BLOOD. (pp. 412A - 412A). AMER SOC HEMATOLOGY

B

Barnouin, K; Dubuisson, ML; Child, ES; Fernandez de Mattos, S; Glassford, J; Medema, RH; Mann, DJ; (2002) H202 induces a transient multi-phase cell cycle arrest in mouse fibroblasts through modulating cyclin D and p21Cip1 expression. Journal of Biological Chemistry , 277 (16) pp. 13761-13770. Gold open access

Bernstein, H-G; Heinemann, A; Krell, D; Mawrin, C; Bielau, H; Danos, P; Diekmann, S; ... Baumann, B; + view all (2002) Further immunohistochemical evidence for impaired NO signaling in the hypothalamus of depressed patients. Ann N Y Acad Sci , 973 pp. 91-93.

Branson, K; Chopra, R; Kottaridis, PD; McQuaker, G; Parker, A; Schey, S; Chakraverty, RK; ... Mackinnon, S; + view all (2002) Role of nonmyeloablative allogeneic stem-cell transplantation after failure of autologous transplantation in patients with lymphoproliferative malignancies. Journal of Clinical Oncology , 20 (19) pp. 4022-4031. 10.1200/JCO.2002.11.088.

Branson, K; Chopra, R; Kottaridis, PD; McQuaker, G; Parker, A; Schey, S; Chakraverty, RK; ... Mackinnon, S; + view all (2002) Role of nonmyeloablative allogeneic stem-cell transplantation after failure of autologous transplantation in patients with lymphoproliferative malignancies. J CLIN ONCOL , 20 (19) 4022 - 4031. 10.1200/JCO.2002.11.088.

C

Carr, WH; Little, AM; Mocarski, E; Parham, P; (2002) NK-cell mediated lysis of autologous HCMV infected skin fibroblasts is highly variable among NK cell cloes and polyclonal NK-cell lines. Clinical Immunology , 105 pp. 126-140.

Chakrabarti, S; Avivi, I; Mackinnon, S; Ward, K; Kottaridis, PD; Osman, H; Waldmann, H; ... Milligan, DW; + view all (2002) Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality. BRIT J HAEMATOL , 119 (4) 1125 - 1132.

Chakrabarti, S; Mackinnon, S; Chopra, R; Kottaridis, PD; Peggs, K; O'Gorman, P; Chakraverty, R; ... Milligan, DW; + view all (2002) High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution. BLOOD , 99 (12) 4357 - 4363.

Chakrabarti, S.; Mackinnon, S.; Chopra, R.; Kottaridis, P.D.; Peggs, K.; O'Gorman, P.; Chakraverty, R.; ... Milligan, D.W.; + view all (2002) High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution. Blood , 99 (12) pp. 4357-4363. 10.1182/blood.V99.12.4357. Green open access
file

Chakraverty, R; Peggs, K; Chopra, R; Milligan, DW; Kottaridis, PD; Verfuerth, S; Geary, J; ... Mackinnon, S; + view all (2002) Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen. BLOOD , 99 (3) 1071 - 1078.

Chantret, I; Dupré, T; Delenda, C; Bucher, S; Dancourt, J; Barnier, A; Charollais, A; ... Moore, SEH; + view all (2002) Congenital disorders of glycosylation type Ig is defined by a deficiency in dolichyl-P-mannose:Man7GlcNAc2-PP-dolichyl mannosyltransferase. J Biol Chem , 277 (28) pp. 25815-25822. 10.1074/jbc.M203285200. Gold open access

Chatterjee, R; KOTTARIDIS, PD; McGarrigle, HH; Linch, DC; (2002) Management of erectile dysfunction by combination therapy with testosterone and sildenafil in recipients of high-dose therapy for haematological malignancies. Bone Marrow Transplantation (607) 610-.

Chatterjee, R; Kottaridis, PD; McGarrigle, HH; Linch, DC; (2002) Management of erectile dysfunction by combination therapy with testosterone and sildenafil in recipients of high-dose therapy for haematological malignancies. Bone Marrow Transplant , 29 (7) pp. 607-610. 10.1038/sj.bmt.1703421.

Chatterjee, R; Kottaridis, PD; McGarrigle, HH; Linch, DC; (2002) Post-transplant complications - Management of erectile dysfunction by combination therapy with testosterone and sildenafil in recipients of high-dose therapy for haematological malignancies. BONE MARROW TRANSPL , 29 (7) 607 - 610. 10.1038/sj/bmt/1703421.

Chen, FE; Aubert, G; Travers, P; Dodi, IA; Madrigal, JA; (2002) HLA tetramers and anti-CMV immune responses: from epitope to immunotherapy. Cytotherapy , 4 (1) pp. 41-48.

Clark, FJ; Chakraverty, R; (2002) Role of dendritic cells in graft-versus-host disease. J HEMATOTH STEM CELL , 11 (4) 601 - 616.

Cohen, H; (2002) Where do we go from here? [Lecture]. Presented at: SHOT annual symposium, London.

Cohen, H; Love, E; Todd, A; Soldan, K; Jones, H; Williamson, LM; (2002) 5 years of serious hazards of transfusion (SHOT): powerful data, slow progress in implementing recommendations. In: (Proceedings) British society for haematology annual scientific meeting.

Colledge, L; Bennett, CL; Reay, PA; Blackburn, CC; (2002) Rapid constitutive generation of a specific peptide-MHC class II complex from intact exogenous protein in immature murine dendritic cells. EUROPEAN JOURNAL OF IMMUNOLOGY , 32 (11) pp. 3246-3255. 10.1002/1521-4141(200211)32:11<3246::AID-IMMU3246>3.0.CO;2-B.

Corell, A; Cox, ST; Soteriou, B; Ramon, D; Madrigal, JA; Marsh, SGE; (2002) Complete cDNA sequences of the HLA-DRB1*14011,*1402,*1403 and*1404 alleles. TISSUE ANTIGENS , 59 (1) pp. 66-69. 10.1034/j.1399-0039.2002.590116.x.

Corell, A; Little, AM; Marsh, SGE; Madrigal, JA; (2002) HLA matching in unrelated stem cell transplantation: what to type for? Inmunologia , 21: pp. 169-177.

Cox, ST; Ogilvie, H; Bohan, EM; Holman, R; Prentice, HG; Potter, M; Madrigal, JA; (2002) Sequence of two new HLA-Cw alleles: HLA-Cw*0313 and HLA-Cw*1208. Tissue Antigens , 59 (1) pp. 49-51.

Crawley, C; Lalanacette, M; Szydlo, R; Gilleece, M; Juliusson, G; Michallet, M; Mackinnon, S; ... Apperley, JF; + view all (2002) Reduced intensity conditioned allografts for myeloma: A study from the Chronic Leukaemia Working Party of the EBMT. In: BLOOD. (pp. 144A - 144A). AMER SOC HEMATOLOGY

D

Davidoff, AM; Nathwani, AC; Spurbeck, WW; Ng, CYC; Zhou, J; Vanin, EF; (2002) rAAV-mediated long-term liver-generated expression of an angiogenesis inhibitor can restrict renal tumor growth in mice. Cancer Res , 62 (11) pp. 3077-3083.

Davies, JK; Koh, MB; Prentice, HG; Lowdell, MW; (2002) Selective allodepletion by immunomagnetic sorting can reduce alloreactivity in vitro, can be done at a clinical scale and preserves in vitro activity against CMV and EBV. BONE MARROW TRANSPL , 29 S45 - S46.

Davis, BA; Porter, JB; (2002) Results of long term iron chelation treatment with deferoxamine. ADV EXP MED BIOL , 509 91 - 125.

Delenda, C; Audit, M; Danos, O; (2002) Biosafety issues in lentivector production. Curr Top Microbiol Immunol , 261 pp. 123-141.

Dodi, IA; Van Rhee, F; Forde, HC; Roura-Mir, C; Jaraquemada, D; Goldman, JM; Madrigal, JA; (2002) CD4(+) bias in T cells cloned from a CML patient with active graft versus leukemia effect. Cytotherapy , 4 (4) pp. 353-363.

Donohoe, S; Quenby, S; Mackie, I; Panal, G; Farquharson, R; Malia, R; Kingdom, J; (2002) Fluctuations in levels of antiphospholipid antibodies and increased coagulation activation markers in normal and heparin-treated antiphospholipid syndrome pregnancies. LUPUS , 11 (1) 11 - 20. 10.1191/0961203302lu132oa.

Duarte, R.F.; Chen, F.E.; Lowdell, M.W.; Potter, M.N.; Lamana, M.L.; Prentice, H.G.; Madrigal, J.A.; (2002) Functional impairment of human T-lymphocytes following PHA-induced expansion and retroviral transduction: implications for gene therapy. Gene Therapy , 9 (20) pp. 1359-1368. 10.1038/sj.gt.3301807.

Duarte, RF; Chen, FE; Lowdell, M; Lamana, ML; Potter, M; Bueren, JA; Prentice, HG; (2002) Mechanisms of functional impairment of T lymphocytes following polyclonal expansion for retrovirally mediated gene transfer. TISSUE ANTIGENS , 59 p. 66.

Duarte, RF; Chen, FE; Lowdell, MW; Potter, MN; Lamana, ML; Prentice, HG; Madrigal, JA; (2002) Functional impairment of human T-lymphocytes following PHA-induced expansion and retroviral transduction: Implications for gene therapy. Gene Therapy , 9 (20) pp. 1359-1368. 10.1038/sj.gt.3301807.

Duarte, RF; Chen, FE; Lowdell, MW; Potter, MN; Lamana, ML; Prentice, HG; Madrigal, JA; (2002) Functional impairment of human T-lymphocytes following PHA-induced expansion and retroviral transduction: implications for gene therapy. GENE THER , 9 (20) 1359 - 1368. 10.1038/sj.gt.3301807.

Dunn, PPJ; Cox, ST; Little, AM; (2002) Sequencing protocols for detectio of HLA class I polymorphism. In: Powis, SH and Vaughan, RW, (eds.) Methods in Molecular Biology. (pp. 191-222). Humana Press Inc: Totowa.

Dunne, C; Little, AM; Cox, ST; Masson, D; Crowley, J; Barnes, T; Marsh, SGE; ... Madrigal, JA; + view all (2002) Identification and nucleotide sequence of a new null allele, HLA B*3540N. TISSUE ANTIGENS , 59 (6) pp. 522-524. 10.1034/j.1399-0039.2002.590610.x.

E

Enver, T; Brown, J; Bruno, L; Gale, K; Gupta, R; Heyworth, C; Hoffmann, R; ... Sarno, S; + view all (2002) Transcriptional programming in haematopoietic stem cells. EXPERIMENTAL HEMATOLOGY , 30 (6) p. 37.

Enver, T; Brown, J; Bruno, L; Gupta, R; Heyworth, C; Hoffmann, R; Joshi, C; ... Seidl, T; + view all (2002) Dynamic analysis of stem cell self renewal and differentiation using global gene expression profiling. In: (Proceedings) 44th Annual Meeting of the American-Society-of-Hematology. (pp. 721A-721A). AMER SOC HEMATOLOGY

F

Ferns, RB; Fletcher, H; Bradley, S; Mackinnon, S; Hunt, C; Tedder, RS; (2002) The prospective evaluation of a nested polymerase chain reaction assay for the early detection of Aspergillus infection in patients with leukaemia or undergoing allograft treatment. BRIT J HAEMATOL , 119 (3) 720 - 725.

Fielding, A; (2002) Cancer vaccines: unanswered questions. May 16, 2002, Phacilitate Spring Vaccine Forum, Cancer Vaccines, Paris, France. Expert Rev Vaccines , 1 (2) pp. 131-133. 10.1586/14760584.1.2.131.

Fielding, A; Bucheit, A; Kumar, S; Yu, L; von Messling, V; (2002) Replicating attenuated measles virus can be engineered to enter cells through the CD20 antigen. In: (Proceedings) 44th Annual Meeting of the American-Society-of-Hematology. (pp. 201A-202A). AMER SOC HEMATOLOGY

Fields, Paul Andrew; (2002) Towards gene therapy for haemophilia using muscle as a target: A study of vector transduction and the implications of the immune response. Doctoral thesis (Ph.D), UCL (University College London). Green open access
file

Firat, H; Cochet, M; Rohrlich, P-S; Garcia-Pons, F; Darche, S; Danos, O; Lemonnier, FA; (2002) Comparative analysis of the CD8(+) T cell repertoires of H-2 class I wild-type/HLA-A2.1 and H-2 class I knockout/HLA-A2.1 transgenic mice. Int Immunol , 14 (8) pp. 925-934. 10.1093/intimm/dxf056.

Firat, H; Zennou, V; Garcia-Pons, F; Ginhoux, F; Cochet, M; Danos, O; Lemonnier, FA; ... Charneau, P; + view all (2002) Use of a lentiviral flap vector for induction of CTL immunity against melanoma. Perspectives for immunotherapy. J Gene Med , 4 (1) pp. 38-45.

Forbes, L.V.; Gale, R.E.; Pizzey, A.; Pouwels, K.; Nathwani, A.; Linch, D.C.; (2002) An activating mutation in the transmembrane domain of the granulocyte colony-stimulating factor receptor in patients with acute myeloid leukemia. Oncogene , 21 (39) pp. 5981-5989. 10.1038/sj.onc.1205767.

Forbes, LV; Gale, RE; Pizzey, A; Pouwels, K; Nathwani, A; Linch, DC; (2002) An activating mutation in the transmembrane domain of the granulocyte colony-stimulating factor receptor in patients with acute myeloid leukemia. ONCOGENE , 21 (39) 5981 - 5989. 10.1038/sj.onc.1205767.

Foroni, L; Hoffbrand, AV; (2002) Molecular analysis of minimal residual disease in adult acute lymphoblastic leukaemia. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY , 15 (1) pp. 71-90. 10.1053/beha.2002.0186.

Foroni, L; Mortuza, YF; Hoffbrand, AV; (2002) Molecular investigation of minimal residual disease in adult acute lymphoblastic leukemia of B lineage. In: Zipf, TF and Johnson, DA, (eds.) Leukemia and Lymphoma: detection of minimal residual disease. (pp. 97-118). Human Press Inc: Totowa.

G

Gale, RE; (2002) Basic sciences of the myeloproliferative diseases: Pathogenic mechanisms of ET and PV. INT J HEMATOL , 76 305 - 310.

Gameiro, P; Moreira, I; Yetgin, S; Papaioannou, M; Potter, MN; Prentice, HG; Hoffbrand, AV; (2002) Polymerase chain reaction (PCR)- and reverse transcription PCR-based minimal residual disease detection in long-term follow-up of childhood acute lymphoblastic leukaemia. BRITISH JOURNAL OF HAEMATOLOGY , 119 (3) pp. 685-696. 10.1046/j.1365-2141.2002.03911.x.

Gameiro, P; Mortuza, FY; Hoffbrand, AV; Foroni, L; (2002) Minimal residual disease monitoring in adult T-cell acute lymphoblastic leukemia: a molecular based approach using T-cell receptor gamma and delta gene rearrangements. HAEMATOLOGICA , 87 (11) pp. 1126-1134. Gold open access

Ganeshaguru, K; Wickremasinghe, RG; Jones, DT; Gordon, M; Hart, SM; Virchis, AE; Prentice, HG; ... Mehta, AB; + view all (2002) Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro. Haematologica , 87 (2) pp. 167-176. Gold open access

Ganeshaguru, K; Wickremasinghe, RG; Jones, DT; Gordon, M; Hart, SM; Virchis, AE; Prentice, HG; ... Mehta, AB; + view all (2002) Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro. HAEMATOLOGICA , 87 (2) 167 - 176. Gold open access

Gardiner, C; Cooper, PC; Makris, M; Mackie, IJ; Malia, RG; Machin, SJ; (2002) An evaluation of screening tests for defects in the protein C pathway: commercial kits lack sensitivity and specificity. BLOOD COAGUL FIBRIN , 13 (2) 155 - 163.

Gardiner, C; Mackie, IJ; Furrs, SA; Piegsa, K; Guillebaud, J; Machin, SJ; (2002) Acquired resistance to activated protein C is more pronounced in women receiving combined oral contraceptives containing desogestrel than levonorgestrel and is associated with low protein S levels. In: BLOOD. (pp. 113B - 113B). AMER SOC HEMATOLOGY

Geary, JE; Verfuerth, S; Thomas, AC; Peggs, KS; Mackinnon, S; (2002) Kinetics of lineage-specific chimerism following an alemtuzumab (Campath-1H) reduced intensity regimen and the effect on chimerism of donor leukocyte infusions. In: BLOOD. (pp. 398B - 399B). AMER SOC HEMATOLOGY

Gerrard, G; Ganeshaguru, K; Baker, R; Potter, M; Prentice, HG; Burgess, M; Herbert, L; ... Mehta, AB; + view all (2002) Inhibition of P-gp activity in aml patients treated with zosuquidar trihydrochloride (LY335979): in vitro data from a phase 1 trial. BLOOD , 100 67a-.

Gonzalez, M; Quezada, SA; Blazar, BR; Panoskaltsis-Mortari, A; Rudensky, AY; Noelle, RJ; (2002) The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning. J IMMUNOL , 169 (10) 5581 - 5589.

Grimwade, D; Outram, SV; Flora, R; Ings, SJ; Pizzey, AR; Morilla, R; Craddock, CF; ... Solomon, E; + view all (2002) The T-Lineage-affiliated CD2 gene lies within an open chromatin environment in acute promyelocytic leukemia cells. CANCER RES , 62 (16) 4730 - 4735.

Gupta, R; Bain, BJ; Knight, CL; (2002) Cytogenetic and molecular genetic abnormalities in systemic mastocytosis. Acta Haematol , 107 (2) pp. 123-128. 10.1159/000046642.

Gupta, R; Knight, CL; Bain, BJ; (2002) Receptor tyrosine kinase mutations in myeloid neoplasms. Br J Haematol , 117 (3) pp. 489-508. 10.1046/j.1365-2141.2002.03469.x.

H

Hale, G; Slavin, S; Goldman, JM; Mackinnon, S; Giralt, S; Waldmann, H; (2002) Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nomnyeloablative conditioning? BONE MARROW TRANSPL , 30 (12) 797 - 804. 10.1038/sj.bmt.1703733.

Hanawa, H; Kelly, PF; Nathwani, AC; Persons, DA; Vandergriff, JA; Hargrove, P; Vanin, EF; (2002) Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood. Molecular Therapy , 5 (3) pp. 242-251.

Harrison, C.N.; Donohoe, S.; Carr, P.; Dave, M.; Mackie, I.; Machin, S.J.; (2002) Patients with Essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis. Thrombosis and haemostasis , 87 (5) pp. 802-807. Green open access
file

Harrison, CJ; Foroni, L; (2002) Cytogenetics and molecular genetics of acute lymphoblastic leukemia. Reviews in Clinical and Experimental Hematology , 6 (2) pp. 91-113.

Harrison, CJ; Mazzullo, H; Ross, FM; Cheung, KL; Gerrard, G; Harewood, L; Mehta, A; ... Orchard, KH; + view all (2002) Translocations of 14q32 and deletions of 13q14 are common chromosomal abnormalities in systemic amyloidosis. BRIT J HAEMATOL , 117 (2) 427 - 435.

Harrison, CN; Donohoe, S; Carr, P; Dave, M; Mackie, I; Machin, SJ; (2002) Patients with essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis. THROMB HAEMOSTASIS , 87 (5) 802 - 807.

Harrison, P; Robinson, M; Liesner, R; Khair, K; Cohen, H; Mackie, I; Machin, S; (2002) The PFA-100((R)): a potential rapid screening tool for the assessment of platelet dysfunction. CLIN LAB HAEMATOL , 24 (4) 225 - 232.

Harrison, P; Robinson, M; Liesner, R; Khair, K; Cohen, H; Mackie, I; Machin, S; (2002) The PFA-100®: A potential rapid screening tool for the assessment of platelet dysfunction. Clinical and Laboratory Haematology , 24 (4) pp. 225-232. 10.1046/j.1365-2257.2002.00451.x.

Hart, SM; Foroni, L; (2002) Core binding factor genes and human leukemia. HAEMATOLOGICA , 87 (12) pp. 1307-1323. Gold open access

Heelan, BT; Tormey, V; Amlot, PL; Payne, E; Mehta, A; Webster, AD; (2002) Effect of anti-CD20 (rituximab) on resistant thrombocytopenia in autoimmune lymphoproliferative syndrome. British Journal of Haematology , 118 (4) pp. 1078-1081.

Herrero-Martinez, E; Sabin, CA; Evans, JG; Griffioen, A; Lee, CA; Emery, VC; (2002) The prognostic value of a single hepatitis C virus RNA load measurement taken early after human immunodeficiency virus seroconversion. J INFECT DIS , 186 (4) 470 - 476.

Hoskin, PJ; Smith, P; Linch, DC; (2002) Late morbidity and survival in early stage Hodgkin's disease treated with involved field or wide field radiotherapy alone. In: (pp. 215-).

Hough, RE; Welch, JC; Vora, AJ; (2002) Potency of the graft versus leukaemia (GVL) effect following unrelated donor cord blood (CB) transplant. In: (Proceedings) 44th Annual Meeting of the American-Society-of-Hematology. (pp. 407B-407B). AMER SOC HEMATOLOGY

Howard, J; Hoffbrand, AV; Prentice, HG; Mehta, A; (2002) Mycophenolate mofetil for the treatment of refractory auto-immune haemolytic anaemia and auto-immune thrombocytopenia purpura. BRITISH JOURNAL OF HAEMATOLOGY , 117 (3) pp. 712-715. 10.1046/j.1365-2141.2002.03430.x.

J

Jarvis, M; Marzolini, M; Wang, X; Dickinson, A; (2002) Expression of heat shock protein 60 and 70 in a human in vitro skin explant model of acute graft versus host disease - Quantitative assessment using scanning laser confocal microscopy. In: (pp. S62-S62). NATURE PUBLISHING GROUP

Jennings, I; Greaves, M; Mackie, IJ; Kitchen, S; Woods, TAL; Preston, FE; UK Natl External Quality Assessmen, ; (2002) Lupus anticoagulant testing: improvements in performance in a UKNEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods. BRIT J HAEMATOL , 119 (2) 364 - 369.

Jones, DT; Ganeshaguru, K; Anderson, RJ; Jackson, TR; Bruckdorfer, KR; Low, SY; Palmqvist, L; ... Wickremasinghe, RG; + view all (2002) Albumin activates the AKT signalling pathway and protects B-chronics lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis. Blood 10.1182/blood-2002-07-2143. Green open access
file

K

Kayyali, R; Hider, RC; Porter, JB; (2002) Combined chelation using deferiprone with deferoxamine induces synergistic inhibition of non-heme iron enzymes. In: BLOOD. (pp. 445A - 445A). AMER SOC HEMATOLOGY

Kichler, A; Chillon, M; Leborgne, C; Danos, O; Frisch, B; (2002) Intranasal gene delivery with a polyethylenimine-PEG conjugate. J Control Release , 81 (3) pp. 379-388.

Kirkham, LA; Bateman, AR; Melcher, AA; Vile, RG; Fielding, AK; (2002) Lack of specificity of cell-surface protease targeting of a cytotoxic hyperfusogenic gibbon ape leukaemia virus envelope glycoprotein. JOURNAL OF GENE MEDICINE , 4 (6) pp. 592-600. 10.1002/jgm.306.

Koh, MBC; Cotter, FE; Prentice, HG; Lowdell, MW; (2002) Removal of allo-specific lymphocytes from MHC-mismatched grafts prevents graft-versus-host disease in vivo and retains anti-viral CTL. LEUKEMIA , 16 (3) 411 - 411.

Koh, MBC; Prentice, HG; Corbo, M; Morgan, M; Cotter, FE; Lowdell, MW; (2002) Alloantigen-specific T-cell depletion in a major histocompatibility complex fully mismatched murine model provides effective graft-versus-host disease prophylaxis in the presence of lymphoid engraftment. BRIT J HAEMATOL , 118 (1) 108 - 116.

Kottaridis, P.D.; Gale, R.E.; Langabeer, S.E.; Frew, M.E.; Bowen, D.T.; Linch, D.C.; (2002) Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors. Blood , 100 (7) pp. 2393-2398. 10.1182/blood-2002-02-0420. Green open access
file

Kottaridis, PD; Craddock, C; Chopra, R; Milligan, DW; Vandenberghe, E; Parker, A; Hunter, A; ... Mackinnon, S; + view all (2002) Reduced intensity allogeneic transpalntation in patients above the age of 50 years. In: BLOOD. (pp. 454B - 454B). AMER SOC HEMATOLOGY

Kottaridis, PD; Gale, RE; Holt, M; Wheatley, K; Goldstone, AH; Burnett, AK; Linch, DC; (2002) Consolidation of AML therapy with autograft and allograft procedures does not negate the poor prognostic impact of FLT3 internal tandem duplications: Results from the UK MRC AML 10 and 12 trials. In: BLOOD. (pp. 75A - 75A). AMER SOC HEMATOLOGY

Kottaridis, PD; Gale, RE; Langabeer, SE; Frew, ME; Bowen, DT; Linch, DC; (2002) Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors. BLOOD , 100 (7) 2393 - 2398. 10.1182/blood-2002-02-0420.

Kottaridis, PD; Peggs, K; Schmitz, N; Dreger, P; Boogaerts, MA; Ferrant, A; Demuynck, HM; ... Goldstone, AH; + view all (2002) Survival and freedom from progression in autotransplant lymphoma patients is independent of stem cell source: Further follow-up from the original randomised study to assess engraftment. LEUKEMIA LYMPHOMA , 43 (3) 531 - 536. 10.1080/10428190290012010.

Kralovicova, J; Marsh, SGE; Waller, MJ; Hammarstrom, L; Vorechovsky, I; (2002) The HLA-DRA*0102 allele: Correct nucleotide sequence and associated HLA haplotypes. TISSUE ANTIGENS , 60 (3) pp. 266-267. 10.1034/j.1399-0039.2002.600310.x.

Kyriacou, CA; Goldstone, AH; Taghipour, G; Avivi, I; Kottaridis, PD; Dogan, A; Linch, DC; (2002) Patients with chemosensitive angioimmunoblastic lymphoma (AITL) can be salvaged with autologous stem cell transplantation, irrespectively of the number of previous treatment lines. Analysis of 74 cases from the European Bone Marrow Transplant Registry (EBMT). In: BLOOD. (pp. 644A - 644A). AMER SOC HEMATOLOGY

L

Langabeer, SE; Gale, RE; Harvey, RC; Cook, RW; Mackinnon, S; Linch, DC; (2002) Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transcript levels in patients with chronic myeloid leukaemia. Leukemia , 16 (3) pp. 393-399. 10.1038/sj.leu.2402397.

Langabeer, SE; Gale, RE; Harvey, RC; Cook, RW; Mackinnon, S; Linch, DC; (2002) Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transcript levels in patients with chronic myeloid leukaemia. Leukemia , 16 (3) pp. 393-399. 10.1038/sj.leu.2402392.

Langabeer, SE; Gale, RE; Harvey, RC; Cook, RW; Mackinnon, S; Linch, DC; (2002) Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transript levels in patients with chronic myeloid leukaemia. LEUKEMIA , 16 (3) 393 - 399. 10.1038/sj/leu/2402392.

Langabeer, SE; Gale, RE; Rollinson, SJ; Morgan, GJ; Linch, DC; (2002) Mutations of the AML1 gene in acute myeloid leukemia of FAB types M0 and M7. GENE CHROMOSOME CANC , 34 (1) 24 - 32. 10.1002/gcc.10031.

Langabeer, SE; Gale, RE; Rollinson, SJ; Morgan, GJ; Linch, DC; (2002) Mutations of the AMLI gene in acute myeloid leukemia of FAB types M0 and M7. Genes Chromosomes and Cancer , 34 (1) pp. 24-32. 10.1002/gcc.10031.

Linch, DC; Yung, L; Smith, P; Maclennan, K; Jack, A; Hancock, B; Cunningham, D; ... UK Lymphoma Grp, ; + view all (2002) A randomised trial of CHOP x 6-8 vs CHOP x 3+BEAM + ASCT in 457 patients with poor prognosis histologically aggressive non-Hodgkins lymphoma. BRIT J CANCER , 86 S1 - S2.

Liu, ZD; Kayyali, R; Hider, RC; Porter, JB; Theobald, AE; (2002) Design, synthesis, and evaluation of novel 2-substituted 3-hydroxypyridin-4-ones: Structure-activity investigation of metalloenzyme inhibition by iron chelators. J MED CHEM , 45 (3) 631 - 639. 10.1021/jm010817i.

Lowdell, MW; Craston, R; Samuel, D; Wood, ME; O'Neill, E; Saha, V; Prentice, HG; (2002) Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cells. BRIT J HAEMATOL , 117 (4) 821 - 827.

M

Mackie, IJ; Lawrie, AS; Kitchen, S; Gaffney, PJ; Howarth, D; Lowe, GDO; Martin, J; ... Rumley, A; + view all (2002) A performance evaluation of commercial fibrinogen reference preparations and assays for Clauss and PT-derived fibrinogen. THROMB HAEMOSTASIS , 87 (6) 997 - 1005.

Mackie, IJ; Lawrie, AS; Purdy, G; Williams, T; Machin, SJ; (2002) DX-88, a novel Kunitz-type inhibitor of human plasma kallikrein with potential therapeutic use. In: BLOOD. (pp. 88B - 89B). AMER SOC HEMATOLOGY

Mackie, J; Lawrie, AS; Kitchen, S; Gaffney, PJ; Howarth, D; Lowe, GDO; Martin, J; ... Rumley, A; + view all (2002) A performance evaluation of commercial fibrinogen reference preparations and assays for Clauss and PT-derived fibrinogen. Thromb Haemost , 87 (6) pp. 997-1005.

Mackinnon, S; (2002) Alemtuzumab and reduced intensity conditioning. BLOOD , 100 (4) 1508 - 1509.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update August 2001. Tissue Antigens , 59 (1) pp. 73-74.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update September 2001. Tissue Antigens , 59 (1) pp. 75-76.

Marsh, SGE; (2002) Nomenclature for factors of the HLA System, update September 2001. Eur J Immunogenet , 29 (1) 79-.

Marsh, SGE; (2002) Nomenclature for factors of the HLA system, update April 2002. Eur J Immunogenet , 29 (5) pp. 457-458.

Marsh, SGE; (2002) Nomenclature for factors of the HLA system, update December 2001. EUROPEAN JOURNAL OF IMMUNOGENETICS , 29 (2) p. 117. 10.1046/j.1365-2370.2002.00317.x.

Marsh, SGE; (2002) Nomenclature for factors of the HLA system, update February 2002. Eur J Immunogenet , 29 (3) 277-.

Marsh, SGE; (2002) Nomenclature for factors of the HLA system, update January 2002. Eur J Immunogenet , 29 (3) 275-.

Marsh, SGE; (2002) Nomenclature for factors of the HLA system, update June 2002. Eur J Immunogenet , 29 (5) 461-.

Marsh, SGE; (2002) Nomenclature for factors of the HLA system, update March 2002. Eur J Immunogenet , 29 (3) pp. 279-280.

Marsh, SGE; (2002) Nomenclature for factors of the HLA system, update May 2002. Eur J Immunogenet , 29 (5) 459-.

Marsh, SGE; (2002) Nomenclature for factors of the HLA system, update November 2001. EUROPEAN JOURNAL OF IMMUNOGENETICS , 29 (2) p. 115. 10.1046/j.1365-2370.2002.00316.x.

Marsh, SGE; (2002) Nomenclature for factors of the HLA system, update October 2001. EUROPEAN JOURNAL OF IMMUNOGENETICS , 29 (2) p. 113. 10.1046/j.1365-2370.2002.00315.x.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; Geraghty, DE; ... Terasaki, PI; + view all (2002) Nomenclature for factors of the HLA system, 2002. EUROPEAN JOURNAL OF IMMUNOGENETICS , 29 (6) pp. 463-516. 10.1046/j.1365-2370.2002.00359.x.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; Geraghty, DE; ... Terasaki, PI; + view all (2002) Nomenclature for factors of the HLA system, 2002. Tissue Antigens , 60 (5) pp. 407-464.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; Geraghty, DE; ... Terasaki, PI; + view all (2002) Nomenclature for factors of the HLA system, 2002. Hum Immunol , 63 (12) pp. 1213-1268.

Marsh, SGE; WHO Nomemclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update December 2001. Tissue Antigens , 59 (2) pp. 172-173.

Marsh, SGE; WHO Nomemclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update November 2001. Tissue Antigens , 59 (2) pp. 170-171.

Marsh, SGE; WHO Nomemclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update October 2001. Tissue Antigens , 59 (2) pp. 168-169.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update April 2002. Hum Immunol , 63 (9) pp. 795-796.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update February 2002. Hum Immunol , 63 (6) 514-.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update March 2002. Hum Immunol , 63 (6) pp. 515-516.

Marsh, SGE; WHO Nomenclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, updated May 2002. Hum Immunol , 63 (10) 966-.

Marsh, SGE; Who Nomenclature Committee for Factor of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update February 2002. Tissue Antigens , 59 (3) pp. 237-238.

Marsh, SGE; Who Nomenclature Committee for Factor of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update January 2002. Tissue Antigens , 59 (3) pp. 235-236.

Marsh, SGE; Who Nomenclature Committee for Factor of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update March 2002. Tissue Antigens , 59 (3) pp. 239-240.

Marzolini, MAV; Wynne, H; (2002) Should patients manage their own oral anticoagulation therapy? Reviews in Clinical Gerontology , 12 (4) pp. 275-281.

Mehta, A; (2002) Agalsidase alfa: specific treatment for Fabry disease. Hospital Medicine , 63 (6) pp. 347-350.

Mehta, A; (2002) New developments in the management of Anderson-Fabry disease. QJM , 95 pp. 647-653.

Mezzina, M; Danos, O; (2002) Five years of vector service for gene therapy. Trends Genet , 18 (3) pp. 118-119.

Mills, KI; Gilkes, AF; Linch, DC; Burnett, AK; (2002) Risk group stratification in AML by the use of micro-arrays. In: BLOOD. (pp. 744A - 744A). AMER SOC HEMATOLOGY

Morris, E; Thomson, K; Craddock, C; Milligan, D; Smith, GM; Parker, A; Schey, S; ... Mackinnon, S; + view all (2002) Long-term follow-up of an alemtuzumab (CAMPATH-1H) containing reduced intensity allogeneic transplant regimen for non-Hodgkin's lymphoma (NHL). In: BLOOD. (pp. 40A - 40A). AMER SOC HEMATOLOGY

Mortuza, FY; Papaioannou, M; Moreira, IM; Coyle, LA; Gameiro, P; Gandini, D; Prentice, HG; ... Foroni, L; + view all (2002) Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia. Journal of Clinical Oncology , 20 (4) pp. 1094-1104.

N

Naik, P; Morris, E; Mackinnon, S; Singer, M; (2002) Do critically ill patients with haematological malignancy survive intensive care and beyond? BRIT J ANAESTH , 89 (2) 359P - 359P.

Nash, M; Cohen, H; (2002) Disorders of thrombosis and haemostasis. Surgery , 30 pp. 203-208.

Nathwani, AC; Davidoff, AM; Hanawa, H; Hu, Y; Hoffer, FA; Nikanorov, A; Slaughter, C; ... Nienhuis, AW; + view all (2002) Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques. Blood , 100 (5) pp. 1662-1669. 10.1182/blood-2002-02-0589. Green open access
file

O

Oakley, TJ; Goodwin, A; Chakravety, RK; Hickson, ID; (2002) Inactivation of homologous recombination suppresses defects in topoisomerase III-deficient mutants. DNA REPAIR , 1 (6) pp. 463-482. 10.1016/S1568-7864(02)00032-0.

Orchard, K; Barrington, S; Buscombe, J; Hilson, A; Prentice, HG; Mehta, A; (2002) Fluoro-deoxyglucose positron emission tomography imaging for the detection of occult disease in multiple myeloma. British Journal of Haematology , 117 (1) pp. 133-135.

P

PORTER, J; DAVIS, B; (2002) Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia. Best Practice & Research Clinical Haematology , 15 (2) pp. 329-368. 10.1053/beha.2002.0214.

Payne, EM; Gerrard, G; Ganeshaguru, K; McCullough, H; Ethell, M; Potter, M; Prentice, HG; ... Mehta, AB; + view all (2002) A phase 1 study of the P-glycoprotein inhibitor zosuquidar trihydrochloride (LY335979) in combination with daunorubicin and cytarabine in adult acute myeloid leukemia. In: (Proceedings) 44th Annual Meeting of the American-Society-of-Hematology. (pp. 557A-557A). AMER SOC HEMATOLOGY

Peggs, K; (2002) Donor lymphocyte infusion following reduced intensity allografting. In: BONE MARROW TRANSPLANTATION. (pp. S37 - S38). NATURE PUBLISHING GROUP

Peggs, K; Verfuerth, S; Pizzey, A; Ainsworth, J; Moss, P; Mackinnon, S; (2002) Characterization of human cytomegalovirus peptide-specific CD8(+) T-cell repertoire diversity following in vitro restimulation by antigen-pulsed dendritic cells. BLOOD , 99 (1) 213 - 223.

Peggs, K; Verfuerth, S; Pizzey, A; Ainsworth, J; Moss, P; Mackinnon, S; (2002) Characterization of human cytomegalovirus peptide-specific CD8+ T-cell repertoire diversity following in vitro restimulation by antigen-pulsed dendritic cells. Blood , 99 (1) pp. 213-223. 10.1182/blood.V99.1.213. Green open access
file

Peggs, KS; Mackinnon, S; (2002) Adoptive cellular therapy: a therapeutic reality? Hematology , 7 (3) pp. 127-136. 10.1080/1024533021000013915.

Peggs, KS; Mackinnon, S; (2002) Clinical trials with CMV-specific T cells. CYTOTHERAPY , 4 (1) 21 - 28.

Peggs, KS; Mackinnon, S; Yong, K; (2002) Reduced intensity conditioning and allogeneic stem-cell transplantation: Determining its role in multiple myeloma. J CLIN ONCOL , 20 (20) 4268 - 4268.

Peggs, KS; Morris, EC; Kottaridis, PD; Geary, J; Goldstone, AH; Linch, DC; Mackinnon, S; (2002) Conditioning regimen may influence outcome of ABO incompatible non-myeloablative haemtopoietic allogeneic stem cell transplantation. Blood , 99 pp. 4642-4644.

Peggs, KS; Morris, EC; Kottaridis, PD; Geary, J; Goldstone, AH; Linch, DC; Mackinnon, S; (2002) Outcome of major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation may be influenced by conditioning regimen. BLOOD , 99 (12) 4642 - 4643.

Peggs, KS; Paneesha, S; Kottaridis, PD; Chakraverty, RK; Tobias, G; Reilly, M; Mahendra, P; (2002) Peripheral blood stem cell transplantation for POEMS syndrome. BONE MARROW TRANSPLANTATION , 30 (6) pp. 401-404. 10.1038/sj.bmt.1703670.

Peggs, KS; Thomson, K; Geary, J; Morris, E; Kottaridis, P; Watts, M; Yong, K; ... Mackinnon, S; + view all (2002) Dose escalating donor lymphocyte infusions (DLI) following T-depleted reduced intensity allografting: High response rates associated with conversion to full donor chimerism (FDC) are not durable despite persistent donor chimerism. In: BLOOD. (pp. 177A - 177A). AMER SOC HEMATOLOGY

Peltékian, E; Garcia, L; Danos, O; (2002) Neurotropism and retrograde axonal transport of a canine adenoviral vector: a tool for targeting key structures undergoing neurodegenerative processes. Mol Ther , 5 (1) pp. 25-32. 10.1006/mthe.2001.0517.

Pemberton, PL; Down, JF; Porter, JB; Bromley, LM; (2002) A retrospective observational study of pre-operative sickle cell screening. ANAESTHESIA , 57 (4) 334 - 337.

Perera, D; Pizzey, A; Campbell, A; Katz, M; Porter, J; Petrou, M; Irvine, DS; (2002) Sperm DNA damage in potentially fertile homozygous beta-thalassaemia patients with iron overload. HUM REPROD , 17 (7) 1820 - 1825.

Perez, N; Plence, P; Millet, V; Greuet, D; Minot, C; Noel, D; Danos, O; ... Apparailly, F; + view all (2002) Tetracycline transcriptional silencer tightly controls transgene expression after in vivo intramuscular electrotransfer: application to interleukin 10 therapy in experimental arthritis. Hum Gene Ther , 13 (18) pp. 2161-2172. 10.1089/104303402320987851.

Perez-Rodriguez, M; Arguello, JR; Fischer, G; Corell, A; Cox, ST; Robinson, J; Hossain, E; ... Madrigal, JA; + view all (2002) Further polymorphism of the MICA gene. EUROPEAN JOURNAL OF IMMUNOGENETICS , 29 (1) pp. 35-46. 10.1046/j.0960-7420.2001.00275.x.

Perez-Rodriguez, M; Madrigal, JA; Marsh, SGE; (2002) A novel HLA-DQA1 allele, DQA1*01042. TISSUE ANTIGENS , 59 (5) pp. 440-442. 10.1034/j.1399-0039.2002.590516.x.

Perez-Rodriguez, M; Raimondi, E; Marsh, SGE; Madrigal, JA; (2002) Identification of a new MICA allele, MICA*047. TISSUE ANTIGENS , 59 (3) pp. 216-218. 10.1034/j.1399-0039.2002.590306.x.

Perez-Simon, JA; Kottaridis, PD; Martino, R; Craddock, C; Caballero, D; Chopra, R; Garcia-Conde, J; ... Spanish United Kingdom Collaborat, ; + view all (2002) Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders. BLOOD , 100 (9) 3121 - 3127. 10.1182/blood-2002-03-0701.

Plemper, RK; Hammond, AL; Gerlier, D; Fielding, AK; Cattaneo, R; (2002) Strength of envelope protein interaction modulates cytopathicity of measles virus. JOURNAL OF VIROLOGY , 76 (10) pp. 5051-5061. 10.1128/JVI.76.10.5051-5061.2002.

Porter, JB; Davis, BA; (2002) Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia. BEST PRACT RES CL HA , 15 (2) 329 - 368. 10.1053/beha.2002.0214.

Pulè, MA; Gullmann, C; Dennis, D; McMahon, C; Jeffers, M; Smith, OP; (2002) Increased angiogenesis in bone marrow of children with acute lymphoblastic leukaemia has no prognostic significance. Br J Haematol , 118 (4) pp. 991-998. 10.1046/j.1365-2141.2002.03761.x.

Pérez-Rodríguez, M; Argüello, JR; Fischer, G; Corell, A; Cox, ST; Robinson, J; Hossain, E; ... Madrigal, JA; + view all (2002) Further polymorphism of the MICA gene. European Journal of Immunogenetics , 29 (1) pp. 35-46. 10.1046/j.0960-7420.2001.00275.x.

Q

Quarmby, JW; Engelke, C; Chitolie, A; Morgan, RA; Belli, AM; (2002) Autologous thrombin for treatment of pseudoaneurysms. LANCET , 359 (9310) 946 - 947.

R

Ramon, D; Corell, A; Cox, ST; Soteriou, B; Madrigal, JA; Marsh, SGE; (2002) Complete cDNA sequences of the HLA-DRB1*0402 and DRB1*11041 alleles. EUROPEAN JOURNAL OF IMMUNOGENETICS , 29 (5) pp. 453-455. 10.1046/j.1365-2370.2002.00354.x.

Rew, SB; Lopes, L; Peggs, K; Koishihara, Y; Kosaka, M; Ozaki, S; Chain, B; (2002) Generation of T-cell mediated immune responses to the myeloma antigen, HM1.24. In: BLOOD. (pp. 105A - 105A). AMER SOC HEMATOLOGY

Robinson, SP; Sureda, A; Mackinnon, S; Carella, A; Taghipour, G; Goldstone, AH; Schmitz, N; (2002) Reduced intensity allogeneic stem cell transplantation for Hodgkin's disease: An analysis from the European group for Blood and Marrow Transplantation. In: BLOOD. (pp. 144A - 144A). AMER SOC HEMATOLOGY

Rooney, CM; Bollard, C; Huls, MH; Gahn, B; Gottschalk, S; Wagner, HJ; Anderson, R; ... Heslop, HE; + view all (2002) Immunotherapy for Hodgkin's disease. Annals of Hematology , 81 S39-S42.

Rowntree, C; Duke, V; Panayiotidis, P; Kotsi, P; Palmisano, GL; Hoffbrand, AV; Foroni, L; (2002) Deletion analysis of chromosome 13q14.3 and characterisation of an alternative splice form of LEU1 in B cell chronic lymphocytic leukemia. LEUKEMIA , 16 (7) pp. 1267-1275. 10.1038/sj.leu.2402551.

S

Sabin, CA; Emery, V; Devereux, HL; Griffioen, AA; Bishop, J; Dusheiko, G; Yee, TT; ... Lee, CA; + view all (2002) Long-term patterns of hepatitis C virus RNA concentrations in a cohort of HIV seronegative men with bleeding disorders. J MED VIROL , 68 (1) 68 - 75. 10.1002/jmv.10171.

Sabin, CA; Griffioen, A; Yee, TT; Emery, VC; Herrero-Martinez, E; Phillips, AN; Lee, CA; (2002) Markers of HIV-1 disease progression in individuals with haemophilia coinfected with hepatitis C virus: a longitudinal study. LANCET , 360 (9345) 1546 - 1551.

Schmitz, N; Pfistner, B; Sextro, M; Sieber, M; Carella, AM; Haenel, M; Boissevain, F; ... Diehl, V; + view all (2002) Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial. The Lancet , 359 (9323) pp. 2065-2071. 10.1016/S0140-6736(02)08938-9.

Sepulveda, CAG; Robinson, J; Schilling, HG; Guethlein, LA; Parham, P; Madrigal, JA; Marsh, SGE; (2002) Characterisation of the KIR genes in HLA homozygolis cell lines. TISSUE ANTIGENS , 59 pp. 9-10.

Serra, J; Sales, M; Chitolie, A; Domenech, P; Rossi, E; Borrell, M; Dahlback, B; (2002) Multicentre evaluation of IL Test (TM) Free PS: A fully automated assay to quantify Free Protein S. THROMB HAEMOSTASIS , 88 (6) 975 - 983.

Shah, FT; Westwood, MA; Evans, PJ; Porter, JB; (2002) Discordance in MRI assessment of iron distribution and plasma NTBI between transfusionally iron loaded adults with sickle cell and thalassaemia. In: BLOOD. (pp. 668A - 668A). AMER SOC HEMATOLOGY

Shaw, B; Mehta, AB; (2002) Pancytopenia responding to treatment of hyperthyroidism: a clinical case and review of the literature. Clinical and Laboratory Haematology , 24 pp. 1-3.

Shaw, B; Mehta, AB; (2002) Pancytopenia responding to treatment of hyperthyroidism: a clinical case and review of the literature. Clin Lab Haematol , 24 (6) pp. 385-387.

Shaw, BE; Marsh, SGE; Mayor, NP; Prentice, HG; Pay, AL; Little, AM; Potter, MN; (2002) Donor age is not a significant factor affecting overall survival in HLA matched unrelated donor stem cell transplants. TISSUE ANTIGENS , 59 90 - 91.

Shaw, BE; Pay, AL; Potter, MN; Mayor, N; Prentice, HG; Little, AM; Marsh, SGE; (2002) HLA-DPB1 plays a role in the outcome of unrelated stem cell transplants in pairs completely matched at the other five transplantation loci. BONE MARROW TRANSPL , 29 S25 - S25.

Shaw, BE; Pay, AL; Potter, MN; Prentice, HG; Mayor, N; Marsh, SGE; Madrigal, JA; (2002) The presence of mild acute graft versus host disease in a T cell depleted unrelated donor transplant setting improves overall survival. BONE MARROW TRANSPL , 29 S39 - S39.

Shaw, BE; Pay, AL; Potter, MN; Travers, P; Mayor, N; Prentice, HG; Marsh, SGE; (2002) The importance of patient and donor CMV status in unrelated stem cell transplantation. BONE MARROW TRANSPL , 29 S126 - S126.

Shaw, BE; Potter, MN; Prentice, HG; Mayor, NP; Pay, AL; Marsh, SGE; Madrigal, JA; (2002) Mild acute graft versus host disease improves overall survival in well matched T cell depleted unrelated donor transplants. TISSUE ANTIGENS , 59 124 - 124.

Shaw, BE; Potter, MN; Prentice, HG; Mayor, NP; Pay, AL; Travers, P; Marsh, SGE; (2002) Factors implicated in disease relapse following volunteer donor unrelated stem cell transplantation. TISSUE ANTIGENS , 59 125 - 125.

Sinclair, PB; (2002) A fluorescence in-situ hybridisation and molecular investigation of leukaemia associated abnormalities of chromosome 6q. Doctoral thesis , University of London. Green open access
file

Spanswick, VJ; Craddock, C; Sekhar, M; Mahendra, P; Shankaranarayana, P; Hughes, RG; Hochhauser, D; (2002) Repair of DNA interstrand crosslinks as a mechanism of clinical resistance to melphalan in multiple myeloma. BLOOD , 100 (1) 224 - 229. Green open access
file

Spanswick, VJ; Craddock, C; Sekhar, M; Mahendra, P; Shankaranarayana, P; Hughes, RG; Hochhauser, D; (2002) Repair of DNA interstrand crosslinks as a mechanism of clinical resistance to melphalan in multiple myeloma. Blood , 100 (1) pp. 224-229. 10.1182/blood.v100.1.224.

Starke, R; Drummond, O; MacGregor, I; Biggerstaff, J; Gale, R; Camilleri, R; Mackie, I; ... Harrison, P; + view all (2002) The expression of prion protein by endothelial cells: A source of the plasma form of prion protein? British Journal of Haematology , 119 (3) pp. 863-873. 10.1046/j.1365-2141.2002.03847.x.

Starke, R; Drummond, O; MacGregor, I; Biggerstaff, J; Gale, R; Camilleri, R; Mackie, I; ... Harrison, P; + view all (2002) The expression of prion protein by endothelial cells: a source of the plasma form of prion protein? BRIT J HAEMATOL , 119 (3) 863 - 873.

T

Tedder, RS; Ayliffe, U; Preiser, W; Brink, NS; Grant, PR; Peggs, KS; Mackinnon, S; ... Garson, JA; + view all (2002) Development and evaluation of an internally controlled semiautomated PCR assay for quantification of cell-free cytomegalovirus. J MED VIROL , 66 (4) 518 - 523. 10.1002/jmv.2175.

Thiselton, DL; Alexander, C; Taanman, JW; Brooks, SP; Rosenberg, T; Eiberg, H; Andreasson, S; ... Votruba, M; + view all (2002) A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy. Invest Ophthalmol Vis Sci , 43 (6) pp. 1715-1724.

Tiercy, J-M; Marsh, SGE; Schreuder, GMT; Albert, E; Fischer, G; Wassmuth, R; European Federation for Immunogenetics subcommittee for reportin, ; (2002) Guidelines for nomenclature usage in HLA reports: ambiguities and conversion to serotypes. Eur J Immunogenet , 29 (3) pp. 273-274.

Tiwari, A; Hamilton, G; Seifalian, AM; Lowdell, MW; O'Neill, E; (2002) Regarding "Isolation of endothelial cells and their progenitor cells from human peripheral blood". J VASC SURG , 35 (4) 827 - 827. 10.1067/mva.2002.121064.

V

Verfuerth, S; Pizzey, AR; Geary, J; Thomas, AC; Peggs, KS; Mackinnon, S; (2002) Magnetic sorting of gamma-IFN-producing T lymphocytes following in vitro restimulations by CMV antigen-pulsed dendritic cells results in a much more diverse range of CMV-specific T cells than CMV-pp65-HLA tetramer selection. In: BLOOD. (pp. 173A - 173A). AMER SOC HEMATOLOGY

Vichinsky, E; Harmatz, P; Fung, E; Madden, J; Louie, L; Walter, PB; Killilea, DW; ... Porter, J; + view all (2002) Secondary hemochromatosis in Bthalassemia and sickle cell disease. In: BLOOD. (pp. 24B - 24B). AMER SOC HEMATOLOGY

Virchis, A; Ganeshaguru, K; Hart, S; Jones, D; Fletcher, L; Wright, F; Wickremasinghe, R; ... Mehta, A; + view all (2002) A novel treatment approach for low grade lymphoproliferative disorders using PKC412 (CGP41251), an inhibitor of protein kinase C. Hematol J , 3 (3) pp. 131-136. 10.1038/sj.thj.6200165.

W

Ward, KN; White, RP; Mackinnon, S; Hanna, M; (2002) Human herpesvirus-7 infection of the CNS with acute myelitis in an adult bone marrow recipient. BONE MARROW TRANSPL , 30 (12) 983 - 985. 10.1038/sj.bmt.1703774.

Watts, MJ; Somervaille, TCP; Ings, SJ; Ahmed, F; Khwaja, A; Linch, DC; (2002) Isolex 300i and CliniMACS clinical scale CD34 selection devices: A split harvest comparison. LEUKEMIA , 16 (3) 416 - 416.

Watts, MJ; Somervaille, TCP; Ings, SJ; Ahmed, F; Khwaja, A; Yong, K; Linch, DC; (2002) Variable product purity and functional capacity after CD34 selection: A direct comparison of the CliniMACS® (v2.1) and Isolex® 300i (v2.5) clinical scale devices. British Journal of Haematology , 118 (1) pp. 117-123. 10.1046/j.1365-2141.2002.03561.x.

Watts, MJ; Somervaille, TCP; Ings, SJ; Ahmed, F; Khwaja, A; Yong, K; Linch, DC; (2002) Variable product purity and functional capacity after CD34 selection: a direct comparison of the CliniMACS (v2.1) and Isolex 300i (v2.5) clinical scale devices. Br J Haematol , 118 (1) pp. 117-123. 10.1046/j.1365-2141.2002.03561.x.

Watts, MJ; Somervaille, TCP; Ings, SJ; Ahmed, F; Khwaja, A; Yong, K; Linch, DC; (2002) Variable product purity and functional capacity after CD34 selection: a direct comparison of the CliniMACS((R)) (v2 center dot 1) and Isolex((R)) 300i (v2 center dot 5) clinical scale devices. BRIT J HAEMATOL , 118 (1) 117 - 123.

Westerman, MP; Pizzey, A; Wiener-Well, Y; Ramotar, H; Lawrie, A; Purdy, G; Mackie, I; ... Porter, JB; + view all (2002) Circulating red cell-derived vesicles expressing phosphatidylserine are increased in thalassemia as well as in sickle cell disorders. In: BLOOD. (pp. 237A - 237A). AMER SOC HEMATOLOGY

Woo, YL; Allard, S; Cohen, H; Letsky, E; de Swiet, M; (2002) Danaparoid thromboprophylaxis in pregnant women with heparin-induced thrombocytopenia. BJOG-INT J OBSTET GY , 109 (4) 466 - 468.

Y

Yates, F; Malassis-Séris, M; Stockholm, D; Bouneaud, C; Larousserie, F; Noguiez-Hellin, P; Danos, O; ... Cavazzana-Calvo, M; + view all (2002) Gene therapy of RAG-2-/- mice: sustained correction of the immunodeficiency. Blood , 100 (12) pp. 3942-3949. 10.1182/blood-2002-03-0782.

Yee, TT; Beeton, K; Griffioen, A; Harrington, C; Miners, A; Lee, CA; Brown, SA; (2002) Experience of prophylaxis treatment in children with severe haemophilia. HAEMOPHILIA , 8 (2) 76 - 82.

Yee, TT; Griffioen, A; Subel, B; Dusheiko, G; Patch, D; Lee, CA; (2002) HCV treatment in a cohort of patients with inherited bleeding disorders. In: ANTIVIRAL THERAPY. (pp. L125 - L126). INT MEDICAL PRESS LTD

Yong, K.L.; Fahey, A.; Pahal, G.; Linch, D.C.; Pizzey, A.; Thomas, N.S.B.; Jauniaux, E.; ... Thrasher, A.J.; + view all (2002) Fetal haemopoietic cells display enhanced migration across endothelium. British Journal of Haematology , 116 (2) pp. 392-400. 10.1046/j.1365-2141.2002.03273.x.

Yong, KL; Fahey, A; Pahal, G; Linch, DC; Pizzey, A; Thomas, NSB; Jauniaux, E; ... Thrasher, AJ; + view all (2002) Fetal haemopoietic cells display enhanced migration across endothelium. BRIT J HAEMATOL , 116 (2) 392 - 400.

Yong, KL; Fahey, A; Pizzey, A; Linch, DC; (2002) Influence of cell cycling and cell division on transendothelial migration of CD34(+) cells. BRIT J HAEMATOL , 119 (2) 500 - 509.

This list was generated on Sun Aug 18 05:04:49 2019 BST.